19 results on '"Yoshihama, Tomoko"'
Search Results
2. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer
3. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer
4. Case Series of Mayer–Rokitansky–Küster–Hauser Syndrome: Analysis of 17 Cases
5. Efficacy of high-dose medroxyprogesterone acetate (MPA) for recurrent early-state endometrial cancer and atypical endometrial hyperplasia as a fertility-preserving treatment at our hospital
6. Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer
7. Epidemiology and Etiology of Ovarian Cancer
8. Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients
9. ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer
10. Atypical vessels in hysteroscopy: Usefulness in prediction of malignant diseases in patients treated with tamoxifen
11. Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report
12. Toxicity profile of olaparib maintenance monotherapy for Japanese platinum-sensitive relapsed ovarian, fallopian tube and primary peritoneal cancer patients
13. Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome
14. A prospective cohort study on the safety and efficacy of bevacizumab combined with chemotherapy in Japanese patients with relapsed ovarian, fallopian tube or primary peritoneal cancer
15. Establishment and characterization of a new malignant peritoneal mesothelioma cell line, KOG-1, from the ascitic fluid of a patient with pemetrexed chemotherapy resistance
16. Effect of obesity on operative outcomes of laparoscopic surgery in patients with early stage endometrial cancer
17. GSTP1rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes
18. Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer
19. UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.